Detalhe da pesquisa
1.
Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP).
Pharmacol Res
; 166: 105499, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33607265
2.
Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.
J Cardiovasc Pharmacol Ther
; 28: 10742484231172847, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218974